Inotiv, Inc. — Director's Dealing 2011

Sep 30, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2011-09-20

Reporting Person: Devine John P (VP--Non-Clinical Services)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	100	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Shares	$5.00	2014-12-30	Common Shares (4000)		Direct
Option to Purchase Common Shares	$5.09	2018-09-04	Common Shares (5000)		Direct
Option to Purchase Common Shares	$1.01	2020-08-15	Common Shares (10000)		Direct

Footnotes

F1: 1,000 options vested and became exercisable on each of December 30, 2006, 2007, 2008 and 2009.

F2: 1,250 options vested and became exercisable on each of September 4, 2010 and 2011 and 1,250 options will vest and become exercisable on each of September 4, 2012 and 2013.

F3: 2,500 options will vest and become exercisable on each of August 16, 2012, 2013, 2014 and 2015.